JP5189094B2 - 無差別ｐａｐｃｄ４ｔ細胞エピトープ - Google Patents

無差別ｐａｐｃｄ４ｔ細胞エピトープ Download PDF

Info

Publication number
JP5189094B2
JP5189094B2 JP2009524012A JP2009524012A JP5189094B2 JP 5189094 B2 JP5189094 B2 JP 5189094B2 JP 2009524012 A JP2009524012 A JP 2009524012A JP 2009524012 A JP2009524012 A JP 2009524012A JP 5189094 B2 JP5189094 B2 JP 5189094B2
Authority
JP
Japan
Prior art keywords
peptide
pap
cell
protein
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009524012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500037A5 (https=
JP2010500037A (ja
Inventor
ジャーミー ビー． ウォーラン，
ロリ エー． ジョーンズ，
Original Assignee
デンドレオン コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デンドレオン コーポレイション filed Critical デンドレオン コーポレイション
Publication of JP2010500037A publication Critical patent/JP2010500037A/ja
Publication of JP2010500037A5 publication Critical patent/JP2010500037A5/ja
Application granted granted Critical
Publication of JP5189094B2 publication Critical patent/JP5189094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2009524012A 2006-08-11 2007-08-10 無差別ｐａｐｃｄ４ｔ細胞エピトープ Expired - Fee Related JP5189094B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83705306P 2006-08-11 2006-08-11
US60/837,053 2006-08-11
US11/836,653 US8361479B2 (en) 2006-08-11 2007-08-09 Promiscuous PAP CD4 T cell epitopes
US11/836,653 2007-08-09
PCT/US2007/075704 WO2008022030A2 (en) 2006-08-11 2007-08-10 Promiscuous pap cd4 t cell epitopes

Publications (3)

Publication Number Publication Date
JP2010500037A JP2010500037A (ja) 2010-01-07
JP2010500037A5 JP2010500037A5 (https=) 2011-09-08
JP5189094B2 true JP5189094B2 (ja) 2013-04-24

Family

ID=39082999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009524012A Expired - Fee Related JP5189094B2 (ja) 2006-08-11 2007-08-10 無差別ｐａｐｃｄ４ｔ細胞エピトープ

Country Status (7)

Country Link
US (2) US8361479B2 (https=)
EP (1) EP2056859B1 (https=)
JP (1) JP5189094B2 (https=)
CA (1) CA2660064C (https=)
ES (1) ES2620740T3 (https=)
PL (1) PL2056859T3 (https=)
WO (1) WO2008022030A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2376923A4 (en) * 2008-12-22 2012-08-15 Children S Res Inst METHOD FOR DETECTING SEPSIS
WO2010119307A1 (en) * 2009-04-14 2010-10-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells
GB2484058A (en) * 2009-12-01 2012-04-04 Uni Konstanz Prostate cancer DNA vaccine
FR3000263B1 (fr) * 2012-12-21 2015-03-06 Ingenico Sa Detection d'un dispositif transactionnel
WO2017096247A1 (en) * 2015-12-04 2017-06-08 Mayo Foundation For Medical Education And Research Methods and vaccines for inducing immune responses to multiple different mhc molecules
CN110079539B (zh) * 2018-01-25 2022-07-01 上海惠盾因泰生物科技有限公司 前列腺酸性磷酸酶/粒-巨噬细胞集落刺激因子制备方法
IT202000013243A1 (it) 2020-06-04 2021-12-04 Novamont Spa Processo per la purificazione di una miscela di dioli

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552534A (en) 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
US5550251A (en) 1991-12-12 1996-08-27 The Trustees Of The University Of Pennsylvania Alicyclic peptidomimetics
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
CA2394741A1 (en) * 1999-12-21 2001-06-28 Epimmune Inc. Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
CA2497554A1 (en) 2002-09-20 2004-04-01 Dendreon Corporation Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
CA2500715A1 (en) 2002-10-03 2004-04-15 Epimmune Inc. Hla binding peptides and their uses

Also Published As

Publication number Publication date
EP2056859B1 (en) 2017-01-11
US20130203163A1 (en) 2013-08-08
EP2056859A2 (en) 2009-05-13
US8361479B2 (en) 2013-01-29
US8647865B2 (en) 2014-02-11
ES2620740T3 (es) 2017-06-29
WO2008022030A3 (en) 2008-11-27
PL2056859T3 (pl) 2017-07-31
WO2008022030A2 (en) 2008-02-21
JP2010500037A (ja) 2010-01-07
WO2008022030A9 (en) 2008-04-10
CA2660064A1 (en) 2008-02-21
US20080286293A1 (en) 2008-11-20
CA2660064C (en) 2016-08-09
EP2056859A4 (en) 2010-03-31

Similar Documents

Publication Publication Date Title
EP3068425B1 (en) Methods of using interleukin-10 for treating diseases and disorders
US8647865B2 (en) Promiscuous PAP CD4 T cell epitopes
KR20180101417A (ko) 항원-특이적 cd8+ t 세포의 제조에서 인터루킨-10 및 이의 사용 방법
JP2007528422A (ja) 自己免疫疾患に関与する自己抗原および非自己抗原の同定
CA2456196A1 (en) Compositions and methods for modulation of immune responses
JP4299777B2 (ja) 免疫応答を誘導するための方法および組成物
US20240285737A1 (en) Improved methods of treatment using immunogenic peptides
US20230136112A1 (en) Methods for stratifying diabetes patients
JP5189593B2 (ja) 無差別ＨＥＲ−２／ＮｅｕＣＤ４Ｔ細胞エピトープ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100802

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120801

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121029

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121130

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130122

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130123

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160201

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees